Human recombinant soluble ACE2 (hrsACE2) shows promise for treating severe COVID-19.

Abd El-Aziz, Tarek Mohamed; Al-Sabi, Ahmed; Stockand, James D

Abd El-Aziz, Tarek Mohamed; Al-Sabi, Ahmed; Stockand, James D.

Abd El-Aziz TM; Department of Cellular and Integrative Physiology, University of Texas Health Science Center at San Antonio, San Antonio, TX, 78229-3900, USA. mohamedt1@uthscsa.edu.
Al-Sabi A; Zoology Department, Faculty of Science, Minia University, El-Minia, 61519, Egypt. mohamedt1@uthscsa.edu.
Stockand JD; College of Engineering and Technology, American University of the Middle East, Kuwait, Kuwait.

Signal Transduct Target Ther ; 5(1): 258, 2020 11 03.

Article in English | MEDLINE | ID: covidwho-965047

Subject(s)

Betacoronavirus; Coronavirus Infections; Pandemics; Peptidyl-Dipeptidase A; Pneumonia, Viral; COVID-19; Humans; SARS-CoV-2

Fulltext

XML

PubMed Links

Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: Pneumonia, Viral / Coronavirus Infections / Peptidyl-Dipeptidase A / Pandemics / Betacoronavirus Limits: Humans Language: English Journal: Signal Transduct Target Ther Year: 2020 Document Type: Article Affiliation country: S41392-020-00374-6

Similar

MEDLINE

LILACS

LIS

Fulltext

XML

PubMed Links

Search on Google